Richard H. Fearon, who serves on the board of Waters Corp (NASDAQ:WAT), acquired a total of 1,000 shares of the company's common stock on March 6, 2026, for an aggregate cost of $306,340. The transactions were completed in multiple tranches at per-share prices spanning $305.84 to $306.49. After these purchases, Fearon's direct holdings in Waters stand at 3,302 shares.
This insider purchase arrives against a backdrop of recent weakness in the stock, which has fallen 21% year-to-date. InvestingPro analysis cited in company coverage indicates Waters is currently slightly overvalued relative to its Fair Value. The firm is noted as having a market capitalization of $29.4 billion and trading at a price-to-earnings ratio of 28.1. InvestingPro Tips included with the coverage indicate net income is expected to grow this year, and the platform offers 12 additional ProTips plus detailed Pro Research Reports for Waters and more than 1,400 other U.S. equities for subscribers seeking expanded analysis.
Market participants have also seen a string of analyst updates following Waters' fourth-quarter results. Stifel kept its Hold rating with a $380 price target, flagging software transition challenges as a consideration. UBS trimmed its price target from $395 to $370 and retained a Neutral rating, citing execution risks tied to Waters' purchase of Becton Dickinson's Life Sciences businesses. TD Cowen likewise lowered its target, moving it to $373 from $400 and maintaining a Hold stance after the stock dropped about 14% in the wake of the earnings release.
Not all analyst moves were defensive. Barclays resumed coverage with an Overweight rating and placed a $400 price target on the stock, pointing to potential upside connected to the acquisition. Evercore ISI also resumed coverage, assigning an In Line rating and a $360 price objective while acknowledging a recent 13% decline in Waters' shares. Together, these updates show a range of views on the company's growth trajectory and the execution risks associated with its recent merger activity.
The director's purchase represents a modest increase in insider ownership relative to the size of the company, while the analyst commentary highlights the centrality of the acquisition's integration and software transitions to near-term performance. Investors monitoring Waters will likely weigh the insider transaction alongside the mixed analyst outlook and the valuation signals provided by InvestingPro's assessment.
Summary
Waters Corp director Richard H. Fearon bought 1,000 shares on March 6, 2026, spending $306,340 across transactions at prices between $305.84 and $306.49. Fearon now directly owns 3,302 shares. The purchase occurs as the stock is down 21% YTD, with analysts offering differing ratings and price targets amid concerns over software transitions and the execution of the Becton Dickinson Life Sciences acquisition.
Key points
- Insider purchase: Director Richard H. Fearon bought 1,000 shares for $306,340 on March 6, 2026, at prices from $305.84 to $306.49.
- Valuation and performance: Waters is down 21% year-to-date and InvestingPro labels the stock slightly overvalued relative to Fair Value; market cap is $29.4 billion and P/E is 28.1.
- Analyst divergence: Multiple firms have adjusted ratings and price targets after the fourth-quarter report and amid concerns over acquisition execution and software transitions.
Risks and uncertainties
- Execution risk from acquisition activity - Analysts cited execution challenges tied to Waters' acquisition of Becton Dickinson's Life Sciences businesses; this affects M&A and healthcare equipment sectors.
- Operational transition risk - Software transition challenges were noted by at least one analyst, posing a risk to near-term operational performance, relevant to software integration within life sciences instruments.
- Valuation and market reaction - The stock's 21% year-to-date decline and InvestingPro's view that it is slightly overvalued introduce uncertainty for equity investors assessing entry points.